Detailed Information
Cited 4 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
LEAP-014: An open-label, randomized, phase 3 study of first-line lenvatinib plus pembrolizumab plus chemotherapy in esophageal squamous cell carcinoma
- Authors
- Sun, JM[Sun, Jong-Mu]; Enzinger, PC[Enzinger, Peter C.]; Adenis, A[Adenis, Antoine]; Shah, MA[Shah, Manish A.]; Kato, K[Kato, Ken]; Bennouna, J[Bennouna, Jaafar]; Doi, T[Doi, Toshihiko]; Hawk, NN[Hawk, Natalyn Nicole]; Yu, L[Yu, Li]; Shah, S[Shah, Sukrut]; Bhagia, P[Bhagia, Pooja]; Shen, L[Shen, Lin]
- Issue Date
- 1-Feb-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.4
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 4
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.